References
1. Freedman RR. Hot flashes: behavioral treatments, mechanisms, and
relation to sleep. The American journal of medicine. 2005 Dec 19;118
Suppl 12B:124-30.
2. Maclennan AH, Broadbent JL, Lester S, Moore V. Oral oestrogen and
combined oestrogen/progestogen therapy versus placebo for hot flushes.
Cochrane database of systematic reviews (Online). 2004 Oct
18(4):CD002978.
3. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C,
Stefanick ML, et al. Risks and benefits of estrogen plus progestin in
healthy postmenopausal women: principal results From the Women’s Health
Initiative randomized controlled trial. Jama. 2002 Jul 17;288(3):321-33.
4. Kargozar R, Azizi H, Salari R. A review of effective herbal medicines
in controlling menopausal symptoms. Electron Physician. 2017
Nov;9(11):5826-33.
5. Albertazzi P. A review of non-hormonal options for the relief of
menopausal symptoms. Treat Endocrinol. 2006;5(2):101-13.
6. Singh P, Oehler MK. Hormone replacement after gynaecological cancer.
Maturitas. 2010 Mar;65(3):190-7.
7. Biglia N, Mariani L, Marenco D, Robba C, Peano E, Kubatzki F, et al.
Hormonal replacement therapy after gynaecological cancer.
Gynakologisch-geburtshilfliche Rundschau. 2006;46(4):191-6.
8. Morales L, Neven P, Timmerman D, Christiaens MR, Vergote I, Van
Limbergen E, et al. Acute effects of tamoxifen and third-generation
aromatase inhibitors on menopausal symptoms of breast cancer patients.
Anticancer Drugs. 2004 Sep;15(8):753-60.
9. Nedrow A, Miller J, Walker M, Nygren P, Huffman LH, Nelson HD.
Complementary and alternative therapies for the management of
menopause-related symptoms: a systematic evidence review. Arch Intern
Med. 2006 Jul 24;166(14):1453-65.
10. Freedman RR. Biochemical, metabolic, and vascular mechanisms in
menopausal hot flashes. Fertility and sterility. 1998 Aug;70(2):332-7.
11. Freedman RR, Woodward S, Sabharwal SC. Alpha 2-adrenergic mechanism
in menopausal hot flushes. Obstetrics and gynecology. 1990
Oct;76(4):573-8.
12. Berendsen HH. The role of serotonin in hot flushes. Maturitas. 2000
Oct 31;36(3):155-64.
13. Blum I, Vered Y, Lifshitz A, Harel D, Blum M, Nordenberg Y, et al.
The effect of estrogen replacement therapy on plasma serotonin and
catecholamines of postmenopausal women. Israel journal of medical
sciences. 1996 Dec;32(12):1158-62.
14. Lippert TH, Filshie M, Muck AO, Seeger H, Zwirner M. Serotonin
metabolite excretion after postmenopausal estradiol therapy. Maturitas.
1996 May;24(1-2):37-41.
15. Miller AL. The methylation, neurotransmitter, and antioxidant
connections between folate and depression. Altern Med Rev. 2008
Sep;13(3):216-26.
16. Brocardo PS, Budni J, Kaster MP, Santos AR, Rodrigues AL. Folic acid
administration produces an antidepressant-like effect in mice: evidence
for the involvement of the serotonergic and noradrenergic systems.
Neuropharmacology. 2008 Feb;54(2):464-73.
17. Lucock MD, Green M, Levene MI. Methylfolate modulates potassium
evoked neuro-secretion: evidence for a role at the pteridine cofactor
level of tyrosine 3-hydroxylase. Neurochemical research. 1995
Jun;20(6):727-36.
18. Botez MI, Young SN, Bachevalier J, Gauthier S. Effect of folic acid
and vitamin B12 deficiencies on 5-hydroxyindoleacetic acid in human
cerebrospinal fluid. Annals of neurology. 1982 Nov;12(5):479-84.
19. Gaweesh SS, Abdel-Gawad MM, Nagaty AM, Ewies AA. Folic acid
supplementation may cure hot flushes in postmenopausal women: a
prospective cohort study. Gynecol Endocrinol. 2010 Sep;26(9):658-62.
20. Grodnitskaya E, Kurtser MA. Effect of folic acid supplementation on
hot flushes in healthy menopausal women. Climacteric. 2011 Jun
2011;14:87.
21. Bani S, Hasanpour S, Farzad Rik L, Hasankhani H, Sharami SH. The
effect of folic Acid on menopausal hot flashes: a randomized clinical
trial. J Caring Sci. 2013 Jun;2(2):131-40.
22. Jahdi F, Chamani M, Neisani SL, Haghani H, Mojab F. Comparing the
effect of Omega3 and that of Folic Acid on menopause-related hot
flashes. Complementary Medicine Journal. 2018;3(28):2353.
23. Gaweesh S, Ewies AA. Folic acid supplementation cures hot flushes in
postmenopausal women. Med Hypotheses. 2010 Feb;74(2):286-8.
24. Sloan JA, Loprinzi CL, Novotny PJ, Barton DL, Lavasseur BI,
Windschitl H. Methodologic lessons learned from hot flash studies. J
Clin Oncol. 2001 Dec 1;19(23):4280-90.
25. (MHRA) MaHpRA. Find product information about medicines. Last
accessed 28 December 2019 on:
https://wwwgovuk/government/organisations/medicines-and-healthcare-products-regulatory-agency.
2019.
26. Greene JG. A factor analytic study of climacteric symptoms. J
Psychosom Res. 1976;20(5):425-30.
27. Greene JG, Cooke DJ. Life stress and symptoms at the climacterium.
Br J Psychiatry. 1980 May;136:486-91.
28. Greene JG. Constructing a standard climacteric scale. Maturitas.
1998 May 20;29(1):25-31.
29. Utian WH, Janata JW, Kingsberg SA, Schluchter M, Hamilton JC. The
Utian Quality of Life (UQOL) Scale: development and validation of an
instrument to quantify quality of life through and beyond menopause.
Menopause (New York, NY. 2002 Nov-Dec;9(6):402-10.
30. Little R, Yau L. Intent-to-Treat Analysis for Longitudinal Studies
with Drop-Outs. Biometrics. 1996;52(4):1324-33.
31. Bottiglieri T. Homocysteine and folate metabolism in depression.
Progress in neuro-psychopharmacology & biological psychiatry. 2005
Sep;29(7):1103-12.
32. Bottiglieri T, Hyland K, Laundy M, Godfrey P, Carney MW, Toone BK,
et al. Folate deficiency, biopterin and monoamine metabolism in
depression. Psychological medicine. 1992 Nov;22(4):871-6.
33. Abou-Saleh MT, Anderson DN, Collins J, Hughes K, Cattell RJ, Hamon
CG, et al. The role of pterins in depression and the effects of
antidepressive therapy. Biological psychiatry. 1995 Oct 1;38(7):458-63.
34. Hyndman ME, Verma S, Rosenfeld RJ, Anderson TJ, Parsons HG.
Interaction of 5-methyltetrahydrofolate and tetrahydrobiopterin on
endothelial function. American journal of physiology. 2002
Jun;282(6):H2167-72.
35. Botez MI, Young SN, Bachevalier J, Gauthier S. Folate deficiency and
decreased brain 5-hydroxytryptamine synthesis in man and rat. Nature.
1979 Mar 8;278(5700):182-3.
36. Korevaar WC, Geyer MA, Knapp S, Hsu LL, Mandell AJ. Regional
distribution of 5-methyltetrahydrofolic acid in brain. Nature: New
biology. 1973 Oct 24;245(147):244-5.
37. Butterworth CE, Jr., Tamura T. Folic acid safety and toxicity: a
brief review. The American journal of clinical nutrition. 1989
Aug;50(2):353-8.
38. Hellstrom L. Lack of toxicity of folic acid given in pharmacological
doses to healthy volunteers. Lancet. 1971 Jan 9;1(7689):59-61.
39. Vollset SE, Clarke R, Lewington S, Ebbing M, Halsey J, Lonn E, et
al. Effects of folic acid supplementation on overall and site-specific
cancer incidence during the randomised trials: meta-analyses of data on
50,000 individuals. Lancet. Mar 23;381(9871):1029-36.